Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Narcolepsy01:07

Narcolepsy

891
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
891
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

3.0K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
3.0K
Sleep Apnea01:21

Sleep Apnea

914
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
914
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

981
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
981
Management of Insomnia01:19

Management of Insomnia

785
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
785
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

1.9K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxidative Stress, Antioxidant Defense, and Sleep-Wake Regulation in Psychiatric Disorders.

Antioxidants (Basel, Switzerland)·2026
Same author

Prevalence, Incidence, and Persistence of Food Allergies Among U.S. Adults: A Longitudinal Population-Based Study.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Prevalence of diagnosed idiopathic hypersomnia among adults in the United States 2019-2023: analysis of healthcare claims.

Sleep advances : a journal of the Sleep Research Society·2026
Same author

Neglected burden of obstructive sleep apnoea: workplace productivity loss in the USA and UK.

Thorax·2026
Same author

Effects of low-sodium oxybate on diary-based sleep time in a clinical study in adults with idiopathic hypersomnia.

Sleep medicine·2025
Same author

Pharmacokinetics and pharmacodynamics of an anti-CSF1 receptor antibody in the intra-articular treatment of tenosynovial giant cell tumor.

European journal of cancer (Oxford, England : 1990)·2025

Related Experiment Video

Updated: May 2, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.9K

Increased mortality in narcolepsy.

Maurice M Ohayon1, Jed Black2, Chinglin Lai3

  • 1Stanford Sleep Epidemiology Research Center, Stanford University, Palo Alto, CA.

Sleep
|March 4, 2014
PubMed
Summary
This summary is machine-generated.

Patients with narcolepsy experience approximately 1.5 times higher mortality rates compared to individuals without the condition. Further research is needed to understand the causes of this increased mortality in narcolepsy patients.

Keywords:
Narcolepsymortality

More Related Videos

Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood
08:20

Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood

Published on: October 2, 2019

10.8K
A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats
07:04

A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats

Published on: August 19, 2018

10.2K

Related Experiment Videos

Last Updated: May 2, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.9K
Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood
08:20

Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood

Published on: October 2, 2019

10.8K
A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats
07:04

A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats

Published on: August 19, 2018

10.2K

Area of Science:

  • Neurology
  • Sleep Medicine
  • Epidemiology

Background:

  • Narcolepsy is a chronic neurological disorder affecting sleep-wake regulation.
  • Understanding the long-term health outcomes, including mortality, is crucial for patient care.

Purpose of the Study:

  • To evaluate the all-cause mortality rate in patients diagnosed with narcolepsy.
  • To compare mortality rates of narcolepsy patients with the general US population and individuals without narcolepsy.

Main Methods:

  • Retrospective analysis of a large, anonymized US population database (Symphony Health Solutions) from 2008-2010.
  • Narcolepsy diagnosis identified via medical claims (ICD-9 347.xx).
  • Mortality data obtained from the Social Security Administration; standardized mortality ratios (SMR) calculated.

Main Results:

  • Patients with narcolepsy exhibited an approximate 1.5-fold excess mortality compared to those without narcolepsy.
  • Higher mortality rates were observed across all age groups in the narcolepsy population.
  • Standardized mortality ratios for narcolepsy patients remained consistent over the study period.

Conclusions:

  • Narcolepsy is associated with a significant increase in all-cause mortality.
  • The underlying causes for the excess mortality in narcolepsy patients require further investigation.
  • Findings highlight the need for comprehensive management strategies for narcolepsy.